반응식
[C:1]1([N:7]2[CH2:12][CH2:11][NH:10][CH2:9][CH2:8]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[CH3:13][S:14]([C:17]1[CH:18]=[C:19]([C:29](O)=[O:30])[C:20]([C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)=[CH:21][CH:22]=1)(=[O:16])=[O:15]>>[CH3:13][S:14]([C:17]1[CH:22]=[CH:21][C:20]([C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)=[C:19]([C:29]([N:10]2[CH2:11][CH2:12][N:7]([C:1]3[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=3)[CH2:8][CH2:9]2)=[O:30])[CH:18]=1)(=[O:15])=[O:16]참가 물질
3
실험 절차
The title compound was prepared according to the procedure E described for Example 9 from phenyl piperazine [189457-54-3] and 4-Methanesulfonyl-biphenyl-2-carboxylic acid (Example V). MS (ISP): 421.3 MH+.
출처 및 근거
- ORD 기록
- ord-c8e1237ddabd4ecc84762ee539f1b69b
- 출처 데이터셋
- uspto-grants-2008_12
- 특허 번호
- US07462617B2
연결된 노트
불러오는 중…